adult T-cell leukemia–lymphoma (ATL) is first divided into two groups: indolent (i.e., smoldering or chronic type) or aggressive (i.e., acute or lymphoma type). The prognosis of indolent ATL is ...

Cord blood transplantation is currently not recommended. AMP: Doxorubicin, ranimustine and prednisone; ATL: Adult T-cell leukemia-lymphoma; CR: Complete remission; NHL: Non-Hodgkin's lymphoma ...

Parathyroid hormone-related protein (PTHrP) plays a primary role in the development of humoral hypercalcemia of malignancy seen in the majority of adult ... ATL cells. Stimulation of Jurkat T ...

having been cleared in Japan in 2022 for relapsed or refractory adult T-cell leukaemia/lymphoma (ATL). PTCL is a group of rare and often aggressive blood cancers, which represent about 10% to 15% ...

a first-in-class dual EZH1 and EZH2 inhibitor for the treatment of patients with relapsed or refractory adult T-cell leukaemia/lymphoma (ATL). The Ministry of Health, Labour and Welfare (MHLW ...

Extranodal, nasal-type natural killer (NK)/T-cell lymphoma (NKCL) is an aggressive malignancy with poor prognosis in which, usually, signal transducer and activator of transcription 3 (STAT3 ...

The research team conducted a study characterizing the effects of H3K27me3 on cancer cells by treating patients who have adult T-cell leukemia/lymphoma (ATL), a rare type of blood cancer, with ...